UK small-cap RNS · 16 Jan 2026
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus the ones that are part of a situation. Not investment advice.
| Time | Company | Mcap ↕ | Type | Announcement | |
|---|---|---|---|---|---|
| 07:00 | Bodycote BOY | £1,541m | Turnaround plan with targets | Acquisition Of Spectrum Thermal Processing
Bodycote, the world's leading provider of specialist thermal processing services, today announces the acquisition of Spectrum Thermal Processing, an Aerospace and Defence focused heat treatment provider based in Cranston, Rhode Island, for a cash … |
|
| 07:00 | Spectra Systems Corporation (DI/REGS) SPSC | £82m | Transformational contract / build-out | Successful Bid for HMRC Vaping Duty Stamps Scheme
Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, security printing, brand protection technologies and gaming security software, is pleased to announce that its security printing arm, Cartor Security Printers … |
|
| 07:00 | Wellnex Life Limited WNX | £3.7m | Turnaround plan with targets | Market Update
Wellnex Life Limited (ASX/AIM:WNX) ("Wellnex Life" or the "Company") announces that Executive Chairman, Ash Vesali, is today providing the following update to shareholders, ahead of the Company's unaudited results for the 6 months to 31 December 2025. |
|
| 07:00 | Shuka Minerals SKA | £6.2m | Balance-sheet stress / refinancing | Completion of LEM and Kabwe Mine acquisition
Shuka Minerals Plc (AIM/AltX: SKA), an African focused mine operator and developer, is pleased to confirm that the Company's acquisition of 100% of Leopard Exploration and Mining Limited (the "Acquisition") has completed. |
|
| 07:00 | CelLBxHealth plc CLBX | £6.8m | Turnaround plan with targets | Preliminary Fourth Quarter 2025 Financial Results
Guildford, UK and Plymouth Meeting, US - 16 January 2026 - CelLBxHealth plc (AIM:CLBX), a leader in circulating tumour cell (CTC) intelligence, with tests and services supporting research, drug development and clinical oncology, announces an update on 2025 … |
|
| 07:00 | Genus GNS | £1,504m | Segment turn | Half Year Trading Update – Ahead of expectations
Genus performed strongly in H1 FY26 and the Board expects to report first half Group adjusted profit before tax (excluding the BCA milestone payment1 referenced below) of approximately £50m in actual currency, which is ahead of our expectations. |